Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 29;36(26):3781-3788.
doi: 10.1038/onc.2016.506. Epub 2017 Feb 13.

CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability

Affiliations

CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability

C Dozier et al. Oncogene. .

Abstract

The phosphatase CDC25A is a key regulator of cell cycle progression by dephosphorylating and activating cyclin-CDK complexes. CDC25A is an unstable protein expressed from G1 until mitosis. CDC25A overexpression, which can be caused by stabilization of the protein, accelerates the G1/S and G2/M transitions, leading to genomic instability and promoting tumorigenesis. Thus, controlling CDC25A protein levels by regulating its stability is a critical mechanism for timing cell cycle progression and to maintain genomic integrity. Herein, we show that CDC25A is phosphorylated on Ser40 throughout the cell cycle and that this phosphorylation is established during the progression from G1 to S phase. We demonstrate that CyclinD-CDK4/CDK6 complexes mediate the phosphorylation of CDC25A on Ser40 during G1 and that these complexes directly phosphorylate this residue in vitro. Importantly, we also find that CyclinD1-CDK4 decreases CDC25A stability in a ßTrCP-dependent manner and that Ser40 and Ser88 phosphorylations contribute to this regulation. Thus our results identify cyclinD-CDK4/6 complexes as novel regulators of CDC25A stability during G1 phase, generating a negative feedback loop allowing control of the G1/S transition.

PubMed Disclaimer

References

    1. EMBO J. 1994 Sep 15;13(18):4302-10 - PubMed
    1. J Biol Chem. 2003 Aug 22;278(34):31838-42 - PubMed
    1. Anticancer Agents Med Chem. 2008 Dec;8(8):825-31 - PubMed
    1. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1392-7 - PubMed
    1. PLoS Genet. 2010 Feb 26;6(2):e1000863 - PubMed

Publication types

LinkOut - more resources